PolyPid Ltd. (PYPD) Tops Q3 EPS by 756c

PolyPid Ltd. (NASDAQ: PYPD) reported Q3 EPS of $3.40, $7.56 better than the analyst estimate of ($4.16).

For earnings history and earnings-related data on PolyPid Ltd. (PYPD) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• What Delta’s report tells investors in American and United
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight